For a copy of this research report please contact your Bell Potter advisor.
March 5th 2021
analyst reports
March 5th 2021
press releases
For a copy of this research report please contact your Bell Potter advisor for the report.
February 25th 2021
analyst reports
February 5th 2021
analyst reports
January 27th 2021
press releases
January 26th 2021
analyst reports
Upcoming Events
Whats next.
September 17th 2021 - September 21st 2021
read more
November 10th 2021 - November 14th 2021
read more
passion.
It takes a great deal of passion on the fight against cancer. We put our heart and soul into winning it.
know-how.
Our goal is to gather the strongest forces, the brightest minds and the most dedicated employees.
research.
Accurate research is the strong foundation for developing potential in effective treatment.
What is LAG3?
Lymphocyte-activation gene 3, or LAG-3 (LAG3), is a cell surface molecule with biologic effects on T cell function.
LAG3 is being used for many cancer immunotherapy treatments including Eftilagimod Alpha from Immutep.
